104 related articles for article (PubMed ID: 19691104)
1. Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping.
Windbergs M; Haaser M; McGoverin CM; Gordon KC; Kleinebudde P; Strachan CJ
J Pharm Sci; 2010 Mar; 99(3):1464-75. PubMed ID: 19691104
[TBL] [Abstract][Full Text] [Related]
2. Analysis of matrix dosage forms during dissolution testing using raman microscopy.
Haaser M; Windbergs M; McGoverin CM; Kleinebudde P; Rades T; Gordon KC; Strachan CJ
J Pharm Sci; 2011 Oct; 100(10):4452-9. PubMed ID: 21560128
[TBL] [Abstract][Full Text] [Related]
3. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
Windbergs M; Strachan CJ; Kleinebudde P
J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
[TBL] [Abstract][Full Text] [Related]
4. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-Stokes Raman scattering microscopy.
Windbergs M; Jurna M; Offerhaus HL; Herek JL; Kleinebudde P; Strachan CJ
Anal Chem; 2009 Mar; 81(6):2085-91. PubMed ID: 19209888
[TBL] [Abstract][Full Text] [Related]
5. Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates.
Windbergs M; Strachan CJ; Kleinebudde P
Int J Pharm; 2009 Nov; 381(2):184-91. PubMed ID: 19782882
[TBL] [Abstract][Full Text] [Related]
6. Influence of structural variations on drug release from lipid/polyethylene glycol matrices.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Sci; 2009 Jul; 37(5):555-62. PubMed ID: 19406229
[TBL] [Abstract][Full Text] [Related]
7. In situ dissolution analysis using coherent anti-Stokes Raman scattering (CARS) and hyperspectral CARS microscopy.
Fussell A; Garbacik E; Offerhaus H; Kleinebudde P; Strachan C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1141-7. PubMed ID: 23994672
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties.
Reitz C; Strachan C; Kleinebudde P
Eur J Pharm Sci; 2008 Nov; 35(4):335-43. PubMed ID: 18765281
[TBL] [Abstract][Full Text] [Related]
9. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
[TBL] [Abstract][Full Text] [Related]
10. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
Güres S; Siepmann F; Siepmann J; Kleinebudde P
Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
[TBL] [Abstract][Full Text] [Related]
11. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution.
Nagy ZK; Balogh A; Vajna B; Farkas A; Patyi G; Kramarics A; Marosi G
J Pharm Sci; 2012 Jan; 101(1):322-32. PubMed ID: 21918982
[TBL] [Abstract][Full Text] [Related]
12. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous UV imaging and raman spectroscopy for the measurement of solvent-mediated phase transformations during dissolution testing.
Østergaard J; Wu JX; Naelapää K; Boetker JP; Jensen H; Rantanen J
J Pharm Sci; 2014 Apr; 103(4):1149-56. PubMed ID: 24496995
[TBL] [Abstract][Full Text] [Related]
14. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
16. Dissolution from solid lipid extrudates containing release modifiers.
Güres S; Kleinebudde P
Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
[TBL] [Abstract][Full Text] [Related]
17. Dissolution of solid lipid extrudates in biorelevant media.
Witzleb R; Müllertz A; Kanikanti VR; Hamann HJ; Kleinebudde P
Int J Pharm; 2012 Jan; 422(1-2):116-24. PubMed ID: 22044538
[TBL] [Abstract][Full Text] [Related]
18. Two-step solid lipid extrusion as a process to modify dissolution behavior.
Windbergs M; Gueres S; Strachan CJ; Kleinebudde P
AAPS PharmSciTech; 2010 Mar; 11(1):2-8. PubMed ID: 20309654
[TBL] [Abstract][Full Text] [Related]
19. In situ measurement of solvent-mediated phase transformations during dissolution testing.
Aaltonen J; Heinänen P; Peltonen L; Kortejärvi H; Tanninen VP; Christiansen L; Hirvonen J; Yliruusi J; Rantanen J
J Pharm Sci; 2006 Dec; 95(12):2730-7. PubMed ID: 16892206
[TBL] [Abstract][Full Text] [Related]
20. Coherent anti-Stokes Raman scattering (CARS) microscopy visualizes pharmaceutical tablets during dissolution.
Fussell AL; Kleinebudde P; Herek J; Strachan CJ; Offerhaus HL
J Vis Exp; 2014 Jul; (89):. PubMed ID: 25045833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
